Skip to main content

Advertisement

Table 5 Number and percentage of infested dogs examined on pre- and post-treatment days

From: Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®

Study days Number of positive dogs per endoparasite species (%)
Trichuris vulpis Ancylostomatidae Capillaria aerophila Toxocara canis Toxascaris leonina Dipylidium caninum a
Day 0 20/41 (48.8) 15/41 (36.6) 8/41 (19.5) 6/41 (14.6) 7/41 (17.1) 3/41 (7.3)
Day 14 1/41 (2.4) 9/41 (22.0) 0/41 (0) 0/41 (0) 0/41 (0) 0/41 (0)
Day 28 2/41 (4.9) 15/41 (36.6) 4/41 (9.8) 0/41 (0) 0/41 (0) 1/41 (2.4)
Day 56 1/41 (2.4) 15/41 (36.6) 0/41 (0) 0/41 (0) 0/41 (0) 0/41 (0)
Day 84 1/39 (2.6) 10/39 (25.6) 0/39 (0) 1/39 (2.6) 0/39 (0) 0/39 (0)
Day 112 0/37 (0) 12/37 (32.4) 0/37 (0) 1/37 (2.7) 0/37 (0) 0/37 (0)
Day 140 0/37 (0) 13/37 (35.1) 0/37 (0) 0/37 (0) 0/37 (0) 0/37 (0)
Day 168 0/37 (0) 10/37 (27) 0/37 (0) 0/37 (0) 0/37 (0) 0/37 (0)
  1. aDogs found infected with Dipylidium caninum were treated with praziquantel, since this tapeworm species is not targeted by the two products tested in the study